Diabetes and its treatment impact prognosis in patients with breast cancer
the ONA take:
Pre-existing diabetes increases risk of total mortality among women with breast cancer. This conclusion comes from a study that assessed the impact of pre-existing diabetes and diabetes treatment on prognosis for patients with breast cancer.
Researchers followed 8,108 women in the Women’s Health Initiative with centrally confirmed breast cancer diagnosed between 1998 an 2013. The women were followed through the date of death or September 20, 2013. Self-reports and face-to-face reviews of current medication containers were used to gather information on the patients’ diabetes and diabetes treatment.
The study showed that risk of overall mortality, among those who took insulin or had longer duration of diabetes in particular, was higher in women with diabetes compared with those who did not have diabetes. However, the disease was not associated with breast cancer-specific mortality regardless of treatment or duration.
This study demonstrates that increased mortality in patients with diabetes is more closely associated with greater risk of dying from diseases other than breast cancer; thus, careful attention to cardiovascular risk factors and other noncancer conditions should be a significant part of the continuum of care for patients with breast cancer.
Pre-existing diabetes increases risk of total mortality among women with breast cancer.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- National Health Care Spending Expected to Grow Five Percent Annually
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- 1 Year of Adjuvant Trastuzumab Improves Long-Term DFS in Early Breast Cancer
- Lenalidomide Maintenance Appears Efficacious for Relapsed DLBCL
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|